Abbott Adding Nutritional For Consumers Using Type 2 Diabetes, Weight Management Drugs

Ensure and Glucerna brand and other adult product sales up 12.5% to account for $1.05bn of $2.04bn in total Q4 nutritionals sales; full-year adult product sales up 6.2%, accounting for $4.2bn of Abbott’s $8.15bn in total nutritionals sales.

• Source: Shutterstock

Adult products led Abbott ’s nutritional business sales growth in 2023 and likely will become a stronger driver in 2024 with the launch of a formulation for people using medications rapidly growing in popularity with the addition of a weight loss indication.

Sales of Abbott’s Ensure and Glucerna brands accounted for $1.05bn of the firm’s $2.04bn in total nutritionals sales for the fourth quarter, with adult product sales up 12.5% from the year-ago period or 13

Adult product sales for the year were up 6.2% reported, 8.8% organic, to account for $4

More from Earnings

More from Business